IGC Pharma, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
Asset Breakdown FY2018
Total Assets: $10.9M
Liabilities Breakdown FY2018
Total Liabilities: $2.8M
Asset Breakdown
Total Assets: $10.9M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $1.7M | 15.3% |
| Accounts Receivable | $558.0K | 5.1% |
| Inventory | $486.0K | 4.5% |
| Property, Plant & Equipment | $6.2M | 57.5% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $128.0K | 1.2% |
| Other Assets | $1.8M | 16.5% |
Liabilities Breakdown
Total Liabilities: $2.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $258.0K | 9.3% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $2.5M | 90.7% |